CY1122842T1 - Μεθοδος για τη διαφοροποιηση του πλειοδυναμου βλαστικου κυτταρου επαγομενη απο το μεσεγχυματικο βλαστικο κυτταρο σε οστεοβλαστες - Google Patents
Μεθοδος για τη διαφοροποιηση του πλειοδυναμου βλαστικου κυτταρου επαγομενη απο το μεσεγχυματικο βλαστικο κυτταρο σε οστεοβλαστεςInfo
- Publication number
- CY1122842T1 CY1122842T1 CY20201100164T CY201100164T CY1122842T1 CY 1122842 T1 CY1122842 T1 CY 1122842T1 CY 20201100164 T CY20201100164 T CY 20201100164T CY 201100164 T CY201100164 T CY 201100164T CY 1122842 T1 CY1122842 T1 CY 1122842T1
- Authority
- CY
- Cyprus
- Prior art keywords
- stem cell
- osteoblasts
- differentiation
- pliorizant
- mesegenus
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0654—Osteocytes, Osteoblasts, Odontocytes; Bones, Teeth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/42—Organic phosphate, e.g. beta glycerophosphate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/76—Undefined extracts from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
- C12N2506/1346—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells
- C12N2506/1369—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells from blood-borne mesenchymal stem cells, e.g. MSC from umbilical blood
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
Abstract
Η παρούσα εφεύρεση αφορά σε μια σύνθεση μέσου το οποίο περιέχει εκχύλισμα Εcklonia cava για τη διαφοροποίηση ενός επαγόμενου πλειοδύναμου βλαστικού κυττάρου, που παράγεται με τη χρήση της σύνθεσης του μέσου σε έναν οστεοβλάστη. Επίσης, η παρούσα εφεύρεση σχετίζεται με τη διαφοροποίηση ενός επαγόμενου πλειοδύναμου βλαστικού κυττάρου με τη χρήση της σύνθεσης του μέσου σε οστεοβλάστες. Κατά τη χρήση της σύνθεσης του μέσου σύμφωνα με την παρούσα εφεύρεση, τα επαγόμενα πλειοδύναμα βλαστικά κύτταρα με τη χρήση των μεσεγχυματικών βλαστικών κυττάρων μπορούν να παραχθούν αποτελεσματικά, και τα πλειοδύναμα βλαστικά κύτταρα που παράχθηκαν μπορούν να χρησιμοποιηθούν ως κυτταρικός θεραπευτικός παράγοντας λόγω της ικανότητας τους να διαφοροποιούνται σε οστεοβλάστες.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020130132057A KR101542848B1 (ko) | 2013-11-01 | 2013-11-01 | 중간엽 줄기세포로부터 유도된 만능 줄기세포를 이용하여 골아세포로 분화시키는 방법 |
PCT/KR2013/009949 WO2015064803A1 (ko) | 2013-11-01 | 2013-11-05 | 중간엽 줄기세포로부터 유도된 만능 줄기세포를 이용하여 골아세포로 분화시키는 방법 |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1122842T1 true CY1122842T1 (el) | 2021-05-05 |
Family
ID=53004391
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20201100164T CY1122842T1 (el) | 2013-11-01 | 2020-02-21 | Μεθοδος για τη διαφοροποιηση του πλειοδυναμου βλαστικου κυτταρου επαγομενη απο το μεσεγχυματικο βλαστικο κυτταρο σε οστεοβλαστες |
Country Status (17)
Country | Link |
---|---|
US (1) | US10053669B2 (el) |
EP (1) | EP3064571B1 (el) |
JP (1) | JP6711758B2 (el) |
KR (1) | KR101542848B1 (el) |
CN (1) | CN105705631B (el) |
AU (1) | AU2013403886B2 (el) |
CY (1) | CY1122842T1 (el) |
DK (1) | DK3064571T3 (el) |
ES (1) | ES2773922T3 (el) |
HR (1) | HRP20200312T1 (el) |
HU (1) | HUE048416T2 (el) |
LT (1) | LT3064571T (el) |
PL (1) | PL3064571T3 (el) |
PT (1) | PT3064571T (el) |
RS (1) | RS60112B1 (el) |
SI (1) | SI3064571T1 (el) |
WO (1) | WO2015064803A1 (el) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RS60200B1 (sr) | 2013-11-01 | 2020-06-30 | Bbhc Co Ltd | Postupak za proizvodnju indukovane pluripotentne matične ćelije iz mezenhimalne matične ćelije i indukovana pluripotentna matična ćelija proizvedena ovim postupkom |
KR101699761B1 (ko) * | 2014-05-23 | 2017-01-25 | 주식회사 비비에이치씨 | 플로로탄닌 분획물을 이용한 중간엽 줄기세포로부터 유도만능 줄기세포를 제조하는 방법 |
CN105802906A (zh) * | 2016-05-27 | 2016-07-27 | 中国医学科学院医学生物学研究所 | 树鼩骨髓间充质干细胞成骨诱导分化培养基及其制备方法与应用 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100449141B1 (ko) * | 2001-04-19 | 2004-09-21 | (주)라이프코드 | 간엽 간세포를 신경세포로 분화시키는 방법 |
WO2006123699A1 (ja) * | 2005-05-17 | 2006-11-23 | Kyowa Hakko Kogyo Co., Ltd. | 幹細胞に対する骨芽細胞への分化促進剤 |
US20100135970A1 (en) | 2006-10-27 | 2010-06-03 | Caritas St. Elizabeth Medical Center Of Boston, In | Methods for Reprogramming Adult Somatic Cells and Uses Thereof |
KR101016761B1 (ko) | 2009-02-26 | 2011-02-25 | 부경대학교 산학협력단 | 피부 미백활성을 갖는 감태 추출물 |
JP2012210154A (ja) | 2009-08-03 | 2012-11-01 | Keio Gijuku | 分化細胞由来多能性幹細胞の樹立方法 |
WO2011037301A1 (ko) * | 2009-09-22 | 2011-03-31 | 서울대학교병원 | 성체세포로부터 만능줄기세포를 유도하는 방법 및 그 방법에 의해 제조된 만능줄기세포 |
JP6263329B2 (ja) | 2009-11-24 | 2018-01-17 | ザ ユニバーシティ オブ コネチカット | ヒト胚性および人工多能性幹細胞の分化 |
KR20120002134A (ko) * | 2010-06-30 | 2012-01-05 | 서울대학교산학협력단 | 지방 기질 세포의 역분화를 유도하는 방법 |
KR20120040488A (ko) | 2010-10-19 | 2012-04-27 | 충남대학교산학협력단 | 곰피와 감태 추출물 유래의 플로로탄닌을 포함하는 화장품 조성물 |
KR101309538B1 (ko) * | 2010-11-17 | 2013-09-23 | 한양대학교 산학협력단 | 엑콜 화합물을 함유하는 암 줄기세포 성장 억제용 조성물 |
KR101887956B1 (ko) | 2011-08-10 | 2018-08-13 | (주)아모레퍼시픽 | 효소 처리 감태 추출물을 포함하는 피부 미백용 조성물 |
-
2013
- 2013-11-01 KR KR1020130132057A patent/KR101542848B1/ko active IP Right Grant
- 2013-11-05 EP EP13896338.4A patent/EP3064571B1/en active Active
- 2013-11-05 DK DK13896338.4T patent/DK3064571T3/da active
- 2013-11-05 ES ES13896338T patent/ES2773922T3/es active Active
- 2013-11-05 RS RS20200233A patent/RS60112B1/sr unknown
- 2013-11-05 US US15/033,393 patent/US10053669B2/en active Active
- 2013-11-05 HU HUE13896338A patent/HUE048416T2/hu unknown
- 2013-11-05 AU AU2013403886A patent/AU2013403886B2/en active Active
- 2013-11-05 WO PCT/KR2013/009949 patent/WO2015064803A1/ko active Application Filing
- 2013-11-05 JP JP2016552368A patent/JP6711758B2/ja active Active
- 2013-11-05 PL PL13896338T patent/PL3064571T3/pl unknown
- 2013-11-05 SI SI201331670T patent/SI3064571T1/sl unknown
- 2013-11-05 CN CN201380080661.3A patent/CN105705631B/zh active Active
- 2013-11-05 LT LTEP13896338.4T patent/LT3064571T/lt unknown
- 2013-11-05 PT PT138963384T patent/PT3064571T/pt unknown
-
2020
- 2020-02-21 CY CY20201100164T patent/CY1122842T1/el unknown
- 2020-02-24 HR HRP20200312TT patent/HRP20200312T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
EP3064571A1 (en) | 2016-09-07 |
EP3064571B1 (en) | 2020-01-22 |
EP3064571A4 (en) | 2017-09-06 |
WO2015064803A1 (ko) | 2015-05-07 |
US10053669B2 (en) | 2018-08-21 |
PL3064571T3 (pl) | 2020-10-05 |
JP2016536019A (ja) | 2016-11-24 |
US20160257935A1 (en) | 2016-09-08 |
RS60112B1 (sr) | 2020-05-29 |
KR20150050863A (ko) | 2015-05-11 |
PT3064571T (pt) | 2020-03-06 |
SI3064571T1 (sl) | 2020-07-31 |
AU2013403886B2 (en) | 2018-04-05 |
DK3064571T3 (da) | 2020-03-16 |
CN105705631A (zh) | 2016-06-22 |
ES2773922T3 (es) | 2020-07-15 |
CN105705631B (zh) | 2021-08-03 |
JP6711758B2 (ja) | 2020-06-17 |
KR101542848B1 (ko) | 2015-08-10 |
LT3064571T (lt) | 2020-06-10 |
HUE048416T2 (hu) | 2020-07-28 |
AU2013403886A1 (en) | 2016-06-23 |
HRP20200312T1 (hr) | 2020-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1122791T1 (el) | Μεθοδος για τη διαφοροποιηση του πλειοδυναμου βλαστικου κυτταρου επαγομενη απο το μεσεγχυματικο βλαστικο κυτταρο σε ηπατοκυτταρο | |
CY1122798T1 (el) | Μεθοδος για τη διαφοροποιηση του πλειοδυναμου βλαστικου κυτταρου επαγομενη απο το μεσεγχυματικο βλαστικο κυτταρο σε χονδροκυτταρο | |
CY1122954T1 (el) | Μεθοδος για τη διαφοροποιηση του πλειοδυναμου βλαστικου κυτταρου επαγομενη απο το μεσεγχυματικο βλαστικο κυτταρο σε νευρωνα | |
CY1122842T1 (el) | Μεθοδος για τη διαφοροποιηση του πλειοδυναμου βλαστικου κυτταρου επαγομενη απο το μεσεγχυματικο βλαστικο κυτταρο σε οστεοβλαστες | |
CY1123348T1 (el) | Μεθοδος για την παρασκευη ενισχυμενων πολυδυναμων βλαστοκυτταρων απο μεσεγχυματικα βλαστοκυτταρα με τη χρηση κλασματος φλοροταννινης | |
AR095774A1 (es) | Anticuerpos anti-il-4 y anticuerpos biespecíficos y sus usos | |
EA201591926A1 (ru) | Способ многоцветной проточной цитометрии для идентификации популяции клеток, в частности мезенхимальных стволовых клеток | |
CY1125278T1 (el) | Μεθοδοι δημιουργιας τραπεζας κυτταρων υψηλης πυκνοτητας | |
CO7461129A2 (es) | Beta-glucosidasa de magnaporthe grisea | |
EA201590488A1 (ru) | Способы модификации клеток-хозяев | |
AR093446A1 (es) | Anticuerpos de antihemaglutinina y metodos de uso | |
GB2548740A (en) | Methods for generation of podocytes from pluripotent stem cells and cells produced by the same | |
AR094375A1 (es) | Métodos de uso de inhibidores del ciclo celular para modular una o más propiedades de un cultivo celular | |
PE20210107A1 (es) | Anticuerpos anti-cd3 y metodos de uso | |
UY35510A (es) | ?composiciones y métodos para mejorar la estabilidad microbiana?. | |
GB2561496A (en) | Devices and methods for simulating a function of a liver tissue | |
EA201391602A1 (ru) | Контролируемое высвобождение иммунодепрессантов из синтетических наноносителей | |
AR090903A1 (es) | Anticuerpos e inmunoconjugados anti-pmel17 | |
GB2562396A (en) | Devices for simulating a function of a liver tissue and methods of use and manufacturing thereof | |
MX2015005627A (es) | Sistemas y metodos para conversion de profundidad de datos sismicos 3d utlizando redes neuronales artificiales. | |
CO2017002253A2 (es) | Compuesto dirigido a il-23a y tnf-alfa | |
PE20150681A1 (es) | Metodo para producir l-aminoacidos | |
EA201500801A1 (ru) | Бензохинолоновые ингибиторы vmat2 | |
RS54073B1 (en) | STROMAL MATERIAL CELLS | |
AU2019268146A1 (en) | Devices and methods including polyacetylenes |